Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 4

Clinical and laboratory features of geriatric patients with suspected immunodeficiency

Fikriye Kalkan(ANKARA BİLKENT ŞEHİR HASTANESİ)0000-0002-7199-436X
Begüm Görgülü Akın(ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-6200-0909
Makbule Seda Bayrak Durmaz(DOKUZ EYLÜL ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-8272-5686
Betül Özdel Öztürk(ANKARA ÜNİVERSİTESİ, ANKARA TIP FAKÜLTESİ)0000-0001-8653-3497
Şadan Soyyiğit(ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-3270-5884
Pages
—
Publication Date
2026-08-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recurrent infections in older adults warrant structured immunological evaluation to ensure timely diagnosis and management of immune disorders.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The increasing life expectancy of the global population has led to a growing number of older adults presenting with recurrent infections and suspected immune dysfunction.
📊
Key Findings & Data:This study aimed to evaluate the clinical, laboratory, and immunological characteristics of elderly patients referred for suspected immunodeficiency and to increase awareness of antibody deficiencies in this age group.
💡
Conclusion & Impact:Recurrent infections in older adults warrant structured immunological evaluation to ensure timely diagnosis and management of immune disorders.
🔬Design:Research Article
📍Scope:2024 Verileri
⚙️Variables:Aging · primary immunodeficiency · elderly

Abstract

Aims: The increasing life expectancy of the global population has led to a growing number of older adults presenting with recurrent infections and suspected immune dysfunction. However, immunodeficiencies remain underrecognized in the geriatric population because clinical manifestations often overlap with age-related immune changes and multiple comorbidities. This study aimed to evaluate the clinical, laboratory, and immunological characteristics of elderly patients referred for suspected immunodeficiency and to increase awareness of antibody deficiencies in this age group. Methods: This retrospective single-center study included patients aged ≥65 years who were referred to the allergy and immunology outpatient clinic with suspected immunodeficiency between January 2024 and December 2025. Patients with secondary immunodeficiency were excluded. Demographic characteristics, comorbidities, presenting symptoms, immunological findings, lymphocyte subset analyses, and serum immunoglobulin levels were extracted from medical records and analyzed. Results: Thirty patients were included, with a mean age of 70.5±5.1 years; 21 (70%) were female. At least one comorbidity was present in 24 patients (80%), most commonly hypertension (36.7%), hypothyroidism (33.3%), and diabetes mellitus (23.3%). Frequent upper respiratory tract infections were the leading reason for referral (53.3%), followed by bronchiectasis (13.3%) and recurrent pneumonia (10.0%). Immunological abnormalities were identified in 20 patients (66.7%). The most common finding was low serum IgM levels (26.7%), followed by common variable immunodeficiency (CVID) (16.7%), low IgA (10.0%), low IgG (10.0%), and IgG subclass deficiency (3.3%). Ten patients (33.3%) demonstrated normal immunological evaluations. No significant differences in immunological abnormalities were observed according to gender, age subgroup, or comorbidity status. Conclusion: Clinically relevant antibody deficiencies may be identified in geriatric patients referred for suspected immunodeficiency, highlighting the importance of appropriate immunological evaluation in selected elderly patients. Low IgM levels and CVID were the most common abnormalities. Recurrent infections in older adults warrant structured immunological evaluation to ensure timely diagnosis and management of immune disorders.

🔖

Cite This Article

Kalkan, F., Akın, B. G., Durmaz, M. S. B., Öztürk, B. Ö., Soyyiğit, Ş. (2026). Clinical and laboratory features of geriatric patients with suspected immunodeficiency. Journal of Medicine and Palliative Care, Volume: 7 Issue: 4. https://doi.org/10.47582/jompac.1975037

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Regina J, Doms J, Kampouri E, et al. Immunodeficiencies in adults: key considerations for diagnosis and management. Clin Rev Allergy Immunol. 2025;68(1):92. doi:10.1007/s12016-025-09103-9
  2. Kindle G, Alligon M, Albert MH, et al. Inborn errors of immunity: manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients. J Hum Immun. 2025;1(3):e20250007. doi:10.70962/jhi.20250007
  3. Goyani P, Christodoulou R, Vassiliou E. Immunosenescence: aging and immune system decline. Vaccines (Basel). 2024;12(12):1314. doi:10.3390/vaccines12121314
  4. Lee KA, Flores RR, Jang IH, Saathoff A, Robbins PD. Immune senescence, immunosenescence and aging. Front Aging. 2022;3:900028. doi:10.3389/fragi.2022.900028
  5. Fetarayani D, Kahdina M, Waitupu A, et al. Immunosenescence and the geriatric giants: molecular insights into aging and healthspan. Med Sci (Basel). 2025;13(3):100. doi:10.3390/medsci13030100
  6. Ventura MT, Scichilone N, Paganelli R, et al. Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms. Clin Mol Allergy. 2017;15:2. doi:10.1186/s12948-017-0059-2
  7. Milgrom H, Huang H. Allergic disorders at a venerable age: a mini-review. Gerontology. 2014;60(2):99-107. doi:10.1159/000355307
  8. Cunha LL, Valsecchi VAdS, Ward LS. Investigating population-level immunosenescence: from bench to bedside. Front Immunol. 2022;13: 949928. doi:10.3389/fimmu.2022.949928
  9. Lang A, Grammatikos A, Ballow M, Otani I, Barmettler S. Risk factors for secondary immunodeficiency in the aged. J Allergy Clin Immunol Pract. 2026. doi:10.1016/j.jaip.2026.05.022
  10. Palacios-Ortega M, Guerra-Galán T, Jiménez-Huete A, et al. Dissecting secondary immunodeficiency: identification of primary immunodeficiency within B-cell lymphoproliferative disorders. J Clin Immunol. 2024;45(1):32. doi:10.1007/s10875-024-01818-2
  11. Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763-1770. doi:10.1016/j.jaip.2019.02.004
  12. Khan SR, van der Burgh AC, Peeters RP, van Hagen PM, Dalm V, Chaker L. Determinants of serum immunoglobulin levels: a systematic review and meta-analysis. Front Immunol. 2021;12:664526. doi:10.3389/fimmu.2021.664526
  13. Listi F, Candore G, Modica MA, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci. 2006;1089:487-495. doi:10.1196/annals.1386.013
  14. Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res Rev. 2021;71:101422. doi:10.1016/j.arr.2021.101422
  15. Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104(3):183-210. doi:10.1016/j.anai.2009.11.009
  16. Danieli MG, Mezzanotte C, Verga JU, et al. Common variable immunodeficiency in elderly patients: a long-term clinical experience. Biomedicines. 2022;10(3):635. doi:10.3390/biomedicines10030635
  17. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308-316. doi:10.1007/s10875-007-9075-1
  18. Zietkiewicz M, Wiesik-Szewczyk E, Matyja-Bednarczyk A, Napiorkowska-Baran K, Zdrojewski Z, Jahnz-Rozyk K. Shorter diagnostic delay in Polish adult patients with common variable immunodeficiency and symptom onset after 1999. Front Immunol. 2020;11:982. doi:10.3389/fimmu.2020.00982
  19. Westh L, Mogensen TH, Dalgaard LS, et al. Identification and characterization of a nationwide Danish adult common variable immunodeficiency cohort. Scand J Immunol. 2017;85(6):450-461. doi:10.1111/sji.12551
  20. Odnoletkova I, Kindle G, Quinti I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13(1):201. doi:10.1186/s13023-018-0941-0
  21. Fortier JC, Haltigan E, Cavero-Chavez V, et al. Clinical and phenotypic characterization of common variable immunodeficiency diagnosed in younger and older adults. J Clin Immunol. 2022;42(6):1270-1279. doi:10.1007/s10875-022-01290-w
  22. Yildiz E, Colkesen F, Evcen R, et al. The clinical and immunological characteristics of common variable immunodeficiency in adults and older adults. North Clin Istanb. 2024;11(3):201-207. doi:10.14744/nci.2023.49699